SLC3A2 and central nervous system cancer: At 8 μM SAHA, the xCT- or CD98 expressions was altered in three tested glioma cell lines human U87, rat F98 and mouse GL261 following 8 hours treatment, which could be demonstrated by real-time RT-PCR (Fig. 2A).